The percutaneous absorption of 17B-Estradiol liquid formulation
碩士 === 高雄醫學院 === 藥學研究所 === 85 === 17β-estradiol長久以來皆是用來當做雌性素補充治療的藥物,所使用 的劑型有口服、皮下注射、植入,或穿皮劑型。而在穿皮製劑與口服製劑 之比較上,口服製劑會因經過肝臟的首渡代謝效應而降低藥效,但穿皮製 劑卻不易受到首渡代謝效應的影響。穿皮劑型可製成軟膏 (ointment)、 凝膠 (gel) 和貼片 (patch) 等,但軟膏和凝膠常會沾到衣服或不小心擦...
Main Authors: | Tsai, Chia-Ling, 蔡佳伶 |
---|---|
Other Authors: | Tsai Yi-Hung |
Format: | Others |
Language: | zh-TW |
Published: |
1997
|
Online Access: | http://ndltd.ncl.edu.tw/handle/99449494701544420226 |
Similar Items
-
Percutaneous 17ß-estradiol replacement therapy in hypertensive postmenopausal women
by: M.C. Osório-Wender, et al.
Published: (1997-09-01) -
Percutaneous Absorption of Diclofenac Sodium Topical Formulation
by: Guu Yih-Bin, et al.
Published: (1995) -
The Effects of 17B-estradiol on Cognition
by: Au, Sin Tung
Published: (2012) -
The Effects of 17B-estradiol on Cognition
by: Au, Sin Tung
Published: (2012) -
Studies on the Actions of 17β-Estradiol in The Vasocontractile Responses
by: Chia-jung Lin, et al.
Published: (1994)